Tag: QRL-101

Innovation, Research

QurAlis gears up for clinical development of therapeutic candidate, QRL-101

June 9, 2021

Via: The Medical News

QurAlis Corporation, a biotech company developing breakthrough precision medicines for ALS and other genetically validated neurodegenerative diseases, today announced the publication of an article in Cell Reports titled Human Amyotrophic Lateral Sclerosis Excitability Phenotype Screen: Target Discovery and Validation by […]